|
FOXK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.7423999959808E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.94179999974043E-07 |
| Normal-vs-Stage2 |
6.416300E-02 |
| Normal-vs-Stage3 |
3.060000E-03 |
| Normal-vs-Stage4 |
9.624500E-02 |
| Stage1-vs-Stage2 |
2.889000E-01 |
| Stage1-vs-Stage3 |
6.464800E-01 |
| Stage1-vs-Stage4 |
5.456000E-01 |
| Stage2-vs-Stage3 |
5.686000E-01 |
| Stage2-vs-Stage4 |
3.397200E-01 |
| Stage3-vs-Stage4 |
4.633000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.36029999884013E-08 |
| Normal-vs-AfricanAmerican |
2.565900E-04 |
| Normal-vs-Asian |
4.002000E-03 |
| Caucasian-vs-AfricanAmerican |
1.765360E-01 |
| Caucasian-vs-Asian |
9.424600E-01 |
| AfricanAmerican-vs-Asian |
5.514600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04719999952196E-07 |
| Normal-vs-Female |
1.59659999998674E-07 |
| Male-vs-Female |
2.565400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.101900E-03 |
| Normal-vs-Extreme_Weight |
1.77823999999438E-05 |
| Normal-vs-Obese |
1.036230E-04 |
| Normal-vs-Extreme_Obese |
2.118000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.669600E-01 |
| Normal_Weight-vs-Obese |
8.408400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.420000E-01 |
| Extreme_Weight-vs-Obese |
7.496800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.044200E-01 |
| Obese-vs-Extreme_Obese |
5.699000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.9088997049721E-10 |
| Normal-vs-Age(41-60Yrs) |
6.13759998380203E-09 |
| Normal-vs-Age(61-80Yrs) |
2.29179999999829E-05 |
| Normal-vs-Age(81-100Yrs) |
5.897800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.549610E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.995140E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.07319999999678E-05 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.400100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.179850E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.032070E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.29769972545546E-10 |
| Normal-VS-Type2 PRCC |
1.560610E-01 |
| Normal-VS-KIRP CIMP |
3.135300E-03 |
| Normal-VS-Unclassified PRCC |
2.610300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.43470000002477E-06 |
| Type1 PRCC-VS-KIRP CIMP |
6.694300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.313000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.377000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.560100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.278400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.221790E-02 |
| Normal-vs-N1 |
1.722380E-03 |
| Normal-vs-N2 |
2.040800E-01 |
| N0-vs-N1 |
5.261600E-02 |
| N0-vs-N2 |
3.114200E-01 |
| N1-vs-N2 |
4.285400E-01 |
|
|
